A graduate of Duke University School of Medicine, Dr. Califf completed his residency in internal medicine at University of California and a fellowship in Cardiology at Duke University. Prior to his appointment as Commissioner, Dr. Califf has served as FDA’s Deputy Commissioner for Medical products and Tobacco from February 2015 and has provided executive leadership to CDER, CBER, CDRH and CTP.
With more than 1200 publications, Dr. Cliff is a frequently cited author in biomedical science and is recognized nationally and internationally for his expertize in cardiovascular medicine, health outcome research, health quality and clinical research. Prior to joining FDA, he was a professor of medicine and VC for clinical and traditional research at DUKE University having served the university as director of the Duke Translational Medicine Institute and founding director of Duke Clinical research institute.
Dr. Cliff has served on the Institute of Medicine (IOM) committees for many important issues besides being on the Board of Scientific Counselors and advisory committees for various National Institutes. He has also served as a member of the FDA Cardiorenal Advisory panel and FDA Science Board’s Subcommittee on Science and Technology.
? For any assistance or questions or clarification please contact us at firstname.lastname@example.org or use our Contact form. Ref: Meet Robert M. Califf, M.D., Commissioner of Food and Drugs.